Hims & Hers Health, Inc.
HIMS
$58.25
-$2.96-4.84%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 85.99% | 69.33% | 56.70% | 50.15% | 55.65% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 85.99% | 69.33% | 56.70% | 50.15% | 55.65% |
| Cost of Revenue | 142.69% | 93.17% | 56.90% | 35.42% | 30.86% |
| Gross Profit | 73.88% | 64.09% | 56.66% | 53.77% | 62.21% |
| SG&A Expenses | 56.92% | 48.46% | 39.76% | 38.14% | 44.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.03% | 57.08% | 43.82% | 38.42% | 42.55% |
| Operating Income | 2,318.55% | 353.60% | 217.83% | 130.54% | 91.38% |
| Income Before Tax | 23,253.41% | 432.44% | 248.34% | 145.16% | 100.87% |
| Income Tax Expenses | -1,656.98% | -2,850.73% | -5,597.45% | 1,172.88% | 997.32% |
| Earnings from Continuing Operations | 7,092.56% | 635.28% | 383.65% | 138.54% | 96.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7,092.56% | 635.28% | 383.65% | 138.54% | 96.05% |
| EBIT | 2,318.55% | 353.60% | 217.83% | 130.54% | 91.38% |
| EBITDA | 2,545.38% | 603.52% | 297.82% | 165.31% | 109.92% |
| EPS Basic | 6,218.70% | 614.87% | 372.93% | 136.91% | 95.76% |
| Normalized Basic EPS | 3,537.76% | 500.55% | 259.42% | 152.85% | 105.70% |
| EPS Diluted | 4,340.74% | 572.02% | 351.63% | 132.82% | 94.41% |
| Normalized Diluted EPS | 4,801.52% | 462.75% | 247.39% | 147.90% | 103.84% |
| Average Basic Shares Outstanding | 3.40% | 3.16% | 2.94% | 2.76% | 2.57% |
| Average Diluted Shares Outstanding | 10.05% | 10.90% | 10.73% | 8.37% | 5.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |